The cell surface-associated extracellular adherence protein (Eap) mediates adherence of 3 Staphylococcus aureus to host extracellular matrix components, and inhibits inflammation, 4 wound healing and angiogenesis. A well-characterized collection of S. aureus and non-5 S. aureus staphylococcal isolates (n = 813) was tested for the presence of the Eap-encoding 6 gene (eap) by PCR to investigate the eap gene as a specific diagnostic tool for identification 7 of S. aureus. Whereas all 597 S. aureus isolates were eap-positive, this gene was not 8 detectable in 216 non-S. aureus staphylococci comprising 47 different species and subspecies 9 of coagulase-negative staphylococci and non-S. aureus coagulase positive/variable 10 staphylococci. Furthermore, non-S. aureus isolates did not express Eap homologs, as verified 11 on transcriptional and protein levels. Based on these data, the sensitivity and specificity of the 12 newly developed PCR targeting the eap gene were both 100 %. Thus, the unique occurrence 13 of Eap in S. aureus offers a promising tool particularly suitable for molecular diagnostics of 14 this pathogen. 15
INTRODUCTION 1
gene, a novel PCR assay for diagnostic purposes was designed and validated in this study. 1 Subsequently, the feasibility of an eap-based approach was systematically analyzed on 2 genomic, transcriptional and protein levels in a large collection of human-and veterinary-3 derived S. aureus and non-S. aureus staphylococcal isolates. 4 
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Bacterial isolates. Overall, 597 S. aureus isolates were tested. The collection encompassed 3 a total of 444 German clinical S. aureus isolates comprising human (n = 429) and veterinary 4 (bovine, n = 10; feline, n = 3; canine, n = 1; equine, n = 1) isolates as well as six reference 5 strains of S. aureus (ATCC 13565, ATCC 14458, ATCC 19095, ATCC 23235, ATCC 27664, 6 ATCC 29213). In addition, S. aureus laboratory strains Newman, Wood 46, and CI7 known 7 to be Eap-producing strains (19) were included serving also as positive controls for the 8 different Eap isoforms. The human isolates were collected and identified during the course of 9 a German multicenter study comprising 219 blood and 210 nasal isolates (40). The veterinary 10 S. aureus isolates were obtained from the Hannover area (Lower Saxonia, Germany). 11
Furthermore, S. aureus isolates from France (n = 12), Hungary (n = 21), Italy (n = 26), Japan 12 (n = 21), Poland (n = 49), and from the United States of America (n = 15) were included. 13
Furthermore, a total of 216 non-S. aureus staphylococci comprising 164 clinical isolates and 14 52 type and reference strains of different coagulase-negative as well as coagulase-positive/-15 variable species and subspecies were studied (Table 1) . Except of the clinically derived 16 S. intermedius (3, 5) and S. pettenkoferi isolates (35), non-S. aureus isolates were (i) recovered 17 from a wide range of clinical specimens derived from e.g. human skin, respiratory tract, 18 isolate), and strain Wood 46, respectively. These primers were compared with the primers 23 EAP-P2wt and EAP-P3wt, which are characterized by the same target nucleotide sequences 24 as described for the published primer pair P2/P3, but without the added enzyme restriction 25 site sequences (Table 2) . 26
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For verification purposes, the five clinical S. aureus isolates tested previously eap-negative 1 by using the primer pair P2/P3 (19) were re-analyzed by applying the EAP-CON1/EAP-2 CON2 primer pair. 3 PCR procedures. DNA was isolated as previously described (4). The diagnostic PCR 4 assays were performed for both target genes in a thermal cycler with a hot bonnet (iCycler, 5 Bio-Rad, Munich, Germany). The PCR reaction mixture consisted of 1 µg DNA, 10 mM Tris-6
HCl [pH 8.3], 10 mM KCl, 3 mM MgCl 2 , 1 µM of the primer, 200 µM of dATP, dCTP, 7 dGTP, and dTTP, 5 U of Taq DNA polymerase (QBIOgene, Heidelberg, Germany) and 8 double-distilled water added to a final volume of 50 µl. A total of 30 PCR cycles were run 9 under the following conditions: DNA denaturation at 95°C for 1 min (5 min for the first 10 cycle), primer annealing at 50°C for 1 min, and DNA extension at 72°C for 2 min. After the 11 final cycle, the reaction was terminated by holding at 72°C for 10 min. 10 µl of the PCR 12 product was analysed on 1% ethidium-bromide stained agarose gel. 13
Southern blot analysis. DNA was restricted with EcoRI, separated on 1% agarose gel, 14 blotted onto a nylon membrane and probed with DIG-labelled PCR products of eap. 15 RNA isolation and Northern blot analysis. For total RNA isolation, bacteria were grown 16 in 5 ml BHI for 18 h at 37 o C with shaking at 160 rpm. Bacteria were pelleted by 17 centrifugation at 4000 rpm for 10 min at 4°C followed by RNA isolation using the RNeasy 18 surface proteins, staphylococci were grown in 5 ml brain heart broth at 37°C for 18 h, then 1 centrifuged at 10,000 x g for 2 min. The pellet was resuspended in extraction buffer (125 mM 2 Tris-HCl pH 7.0 + 2% sodium dodecyl sulfate [SDS, Sigma-Aldrich] ), heated at 95°C for 3 3 min, and then centrifuged at 10,000 x g for 3 min. The supernatant was passed through a Nap-4 10 column (Amersham Pharmacia Biotech Europe, Freiburg, Germany) containing Sephadex 5 G-25 to remove SDS and the eluate was stored at -20C. To 20 µl of cell surface extract, 5 µl 6 of 5x sample buffer (60 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 14.4 mM 2-7 mercaptoethanol and 0.1% bromophenol blue [Merck] ) was added, heated at 95°C for 3 min, 8 then separated in a SDS-PAGE minigel. For Western blot analysis, proteins separated by 9 SDS-PAGE were electrophoretically transferred (Trans-blot SD, Bio-Rad, Munich, Germany) 10 onto a nitrocellulose membrane (Schleicher & Schüll, Dassel, Germany) , and then the 11 membrane was blocked with 3% bovine serum albumin (BSA) fraction V (Sigma, 12
Taufkirchen, Germany). For probing blocked blots, anti-Eap was used and subsequently 13 detected using AP-conjugated anti-rabbit antibody (Dako, Hamburg, Germany) developed in 14 sheep and alkaline phosphatase color reaction (Bio-Rad, Munich, Germany). 15
Polyclonal antibodies. Recombinant Eap (rEap) was expressed and purified as described 16 earlier (19, 20) . Polyclonal antibodies against the recombinant protein were raised separately 17 in two rabbits by standard procedures (17). After collection of preimmune sera, each rabbit 18 was immunized subcutaneously with 50 µg of rEap derived from strain Newman in complete 19 strains of S. aureus tested (Fig.2) . Thus, the sensitivity of the newly developed PCR approach 6 was 100 %. Due to the primer selection targeting the first repeat domain only, different sizes 7 of the PCR products as known for the primer pairs P2/P3 and EAP-P2wt/EAP-P3wt, 8 respectively, were not observed. 9
Moreover, the five clinical S. aureus isolates tested eap-negative in previous study by using 10 the primer pair P2/P3 (19) were now found to be eap-positive applying the newly designed 11 primer pair (data not shown). 12
Prevalence of eap in non-S. aureus bacteria. To analyze the specificity of the newly 13 designed eap-specific primers, the prevalence of the eap gene among 216 non-S. aureus 14 staphylococci comprising 47 different CoNS and coagulase-positive/-variable staphylococcal 15 (sub-) species was investigated at the DNA level. The PCR presented here showed a 100 % 16 specificity, i.e. the eap gene was detected neither in 216 clinical isolates, including a large 17 number of CoNS isolated from blood and considered etiologically relevant, nor in 52 18 staphylococcal type and reference strains obtained from various strain collections (Fig. 2) .
S. capitis (n = 1), S. xylosus (n = 1) were restricted with EcoRI, separated on 1% agarose gel, 1 blotted onto a nylon membrane and probed with a DIG-labelled PCR product of eap from 2 strain Newman using primers EAP-P3wt and EAP-P2wt. All non-S. aureus isolates tested 3
showed negative results with DIG-labelled eap PCR products, but positive results were seen 4 with genomic DNA of S. aureus control strains Newman, Mu-7 and Wood 46 (Fig. 3A) . has anti-inflammatory and immunomodulatory functions in the host indicating that Eap 7 constitutes a potent virulence factor in the course of staphylococcal infections (1, 8, 15, 18, 25) . 8
Thus, Eap acts as a secretable expanded repertoire adhesive molecule (SERAM) (9). 9
In this study, the Eap encoding gene (eap) was studied as a diagnostic target for specific 10 identification of S. aureus by PCR amplification. Whereas sequencing results suggest that the 11 eap sequences are in general highly conserved, size differences are known for the encoding 12 gene as a result of different number of repeats as well as for the translated product, which 13 were additionally determined by an insertional point mutation or ribosomal slippage at the site 14 of a poly(A) region located at the 3´ end of the respective repeat region (19). Thus, the 15 described PCR primer pairs generated to study the size variants (19) do not fulfil the needs (i) 16 to detect eap homologs in other staphylococcal species and (ii) to use this gene as a target for 17 specific and reliable identification of S. aureus. Consequently, a novel primer pair more 18 suitable for diagnostic purposes was generated, based on all known eap nucleotide sequences. 19
Based on previous observations that this gene is highly conserved among S. aureus isolates 20
and that it was shown to be absent in a small collection of S. epidermidis isolates (19, 20) , 21 large collections of staphylococcal species and subspecies comprising different CoNS as well 22 as coagulase-positive/-variable and/or clumping factor-positive/-variable staphylococci from 23 various clinical and geographical sources were analyzed for the presence of eap gene and 24 gene product homologs on DNA, transcriptional and protein levels. To our knowledge, this is 25 currently one of the most comprehensive collections of staphylococcal isolates tested for 26
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on November 13, 2017 by guest http://jcm.asm.org/ Downloaded from validation of a molecular diagnostic target. Noteworthy, the clinical isolates tested previously 1 eap-negative (19), were now shown to harbour in fact the eap gene, demonstrating the 2 superiority of the newly designed primer pair to former applied primers. It also stresses the so 3 far unexceptional possession of this gene by S. aureus. 4
In order to detect putative differences between CoNS strains recovered from the 5 physiological skin flora and those strains involved in clinical significant infections, isolates 6 from a German multicenter study were included in which only CoNS considered etiologically 7 relevant were collected. However, non-S. aureus staphylococci were all eap-negative using 8 the newly designed PCR primers. In order to exclude negative PCR results due to potential 9 DNA sequence heterogeneities of the primer binding sites, Southern blot analyses with DIG-10 labelled eap PCR amplicons were performed. Of particular interest, Southern blot analyses as 11 well as Northern and Western blot analyses gave no positive results for non-S. aureus isolates. 12
Hence, the existence of Eap homologs in other staphylococcal species is highly unlikely. 13
Given the pleiotropic biologic effects of Eap and the prevalence of 100 % for the eap gene, 14 one may speculate that this SERAM may be of crucial importance to S. aureus. However, 15 currently it is unclear why only 70% of isolates tested expressed Eap under in vitro conditions 16 (19) and whether this correlates with specific requirements in a given ecological niche. 17
In the light of the ongoing increase of the prevalence of methicillin-resistant S. aureus 18 strains in hospitals and other health-care facilities worldwide (14) fragments of unknown function, and the fem factors-encoding genes (6, 13, 24, 26, 32, 37) , were 7 used for molecular detection and identification of S. aureus. However, some of these studies 8 concentrated only on a limited number of staphylococcal species. Additionally, target gene-9 negative S. aureus strains as well as target gene homologs in CoNS were observed, hampering 10 both sensitivity and specificity of these molecular approaches (22, 24, 36) . Here, we 11 demonstrate that targeting the eap gene allows appending the diagnostic toolbox. This gene 12 appears to be particularly suitable for molecular diagnostics of S. aureus. Based on these data, 13 the sensitivity and specificity of the eap gene were both remarkably high (i. e. 100 %). 14 In conclusion, Eap was shown to be a virulence factor specifically restricted to S. aureus, 15 occurring in all isolates of this species tested. In contrast, CoNS and other coagulase-16 positive/-variable staphylococcal species were shown to miss the encoding gene as well as 17 homologs of this factor as shown on DNA, transcriptional and protein levels. Thus, Eap 18 seems to be a core trait of S. aureus, offering a promising target for sensitive and specific 19 detection of S. aureus. 20 

